The bulk of the efforts at synthesizing an active GH molecule and extending its short circulating half-life of ∼20-min involved various strategies of pegylation to treat congenital deficiencies in GH production (24). The gene discussed is GH1; the disease is hyperinsulinemic hypoglycemia, familial, 4.